Physician profile
David M Abel
NPI 1598151797
$507.64
in general payments reported to CMS, 2019-2025
12 companies · $53.74 in 2025
The $53.74 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.99 · 2020: $120 · 2022: $43.01 · 2023: $75.30 · 2024: $174 · 2025: $53.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $130.80 | 2022-2025 | Vraylar |
| Lilly USA, LLC | $126.61 | 2020-2024 | Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $47.26 | 2024 | Airsupra |
| Exact Sciences Corporation | $44.99 | 2023-2024 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $28.07 | 2025 | Fanapt |
| Novo Nordisk INC | $22.33 | 2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.45 | 2019 | |
| Allergan, INC. | $20.54 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.14 | 2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $16.66 | 2023 | Shingrix, Bexsero |
| Pfizer INC. | $15.63 | 2023 | |
| Dexcom, INC. | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.